Tetralogy of Fallot Clinical Trial
Official title:
The Effect of Different Contouring Techniques on Cardiac Magnetic Resonance Assessment of Right Ventricular Volumes in Repaired Tetraology of Fallot: Implications on Preoperative Thresholds for Intervention
Patients with repaired tetralogy of Fallot (RTOF) develop chronic pulmonary regurgitation and require monitoring for right ventricular dilatation. Pulmonary valve replacement can prevent irreversible right ventricular (RV) dilatation and dysfunction and cardiac magnetic resonance (CMR) is used to facilitate its optimal timing. The investigators sought to determine whether the choice of myocardial contouring technique affects preoperative RV volumetric thresholds for intervention.
Participants with repaired tetralogy of Fallot (RTOF) will be identified using existing patient electronic records who have developed chronic pulmonary regurgitation and are undergoing monitoring for right ventricular dilatation. Cardiac magnetic resonance (CMR) is used to facilitate its optimal timing. Pulmonary valve replacement can prevent irreversible right ventricular (RV) dilatation and dysfunction and cardiac magnetic resonance (CMR) is used to facilitate its optimal timing. There are different post-processing techniques published for measuring RV volumes on cardiac magnetic resonance imaging (detailed vs. smoothed and manual vs. automated). The primary aim of this study is to identify whether the choice of myocardial contouring technique affects the preoperative RV volumetric thresholds for intervention. As a secondary aim, the investigators will determine the reproducibility of different contouring methods. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02534792 -
Early Revalvulation After Fallot Repair Improves Clinical Outcome
|
N/A | |
Completed |
NCT00536432 -
Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot
|
N/A | |
Not yet recruiting |
NCT05485545 -
Asynchrony in Operated Tetralogy of Fallot
|
N/A | |
Completed |
NCT01941576 -
Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot
|
N/A | |
Active, not recruiting |
NCT03983512 -
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
|
N/A | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01762124 -
Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
|
N/A | |
Active, not recruiting |
NCT02161471 -
Haemodynamics and Function of the Atria in Congenital Heart Disease by Cardiovascular Magnetic Resonance
|
||
Not yet recruiting |
NCT05916976 -
Repaired Tetralogy of Fallot: Risc Score From MRI & Clinical Data to Predict the Need for Change of Treatment
|
N/A | |
Recruiting |
NCT04106479 -
NIRS in Congenital Heart Defects - Correlation With Echocardiography
|
||
Completed |
NCT05579964 -
The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot
|
Phase 2/Phase 3 | |
Recruiting |
NCT05236153 -
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
|
N/A | |
Recruiting |
NCT03049995 -
Stress Echo 2020 - The International Stress Echo Study
|
||
Completed |
NCT02586740 -
Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation
|
N/A | |
Terminated |
NCT00564993 -
Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
|
Phase 3 | |
Recruiting |
NCT05122962 -
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
|
||
Completed |
NCT06097377 -
Lymphatic Magnetic Resonance Imaging Abnormalities in Children With Tetralogy of Fallot: A Case-Control Study
|
||
Completed |
NCT03835494 -
Analysis of RV-Dysfunction in Fallot Patients
|
N/A | |
Not yet recruiting |
NCT03275844 -
Physical Capacity and Activity in Children With Congenital Heart Disease
|
N/A | |
Recruiting |
NCT02590679 -
Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p
|
Phase 2/Phase 3 |